[1] Backhaus E, Berg S, Andersson R, Ockborn G, Malmstrom P, Dahl M, et al. Epidemiology of 337 invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, 338 gender and risk factors. BMC Infect Dis 2016; 16:367.
[2] Chávez-Bueno S, McCracken GH. Bacterial meningitis in children. PediatrClin N Am. 2005;52(3):795–810.
[3] Yao KH, Yang YH. Streptococcus pneumoniae diseases in Chinese children: past, present and future. Vaccine. 2008;26(35):4425–33.
[4] Li C, Feng WY, Lin AW, Zheng G, Wang YC, Han YJ, et al. Clinical characteristics and etiology of bacterial meningitis in Chinese children >28 days of age, January 2014–December 2016: a multicenter retrospective study. Int J Infect Dis. 2018; 74:47–53
[5] Guidelines for antibacterial use in clinical practice. China: Ministry of Health of P.R. China; 2004
[6] Wu Xia, Han Shuzhen, Wang Chuanqing,etal. Clinical characteristics and antimicrobial susceptibility Of pneumococcal meningitis in 20 chndren, Chin J lnfect Chemother,september 2019, V01. 19, No.5 519-523
[7] Fang Boliang, Wang Xiangdie, Qian Sunyan, etal. Analysis of clinical characteristics and prognosis of children with septic shock caused by invasive pneumococcal diseases, Chin J Appl Clin Pediatr, April 2020,Vol. 35, No, 7 555-558
[8] Liu Genmei, Liu Xiuyun, Liu Jun, etal. A single-center study of pneunococcal empyema in children, Chin J Appl Clin Pediatr, April 2020,Vol. 35, No, 8 578-581
[9] D van de Beek, C Cabellos, O Dzupova, S Esposito, M Klein, A T Kloek, S L Leib, B Mourvillier, C Ostergaard, P Pagliano, H W Pfister, R C Read, O Resat Sipahi, M C Brouwer, ESCMID Study Group for Infections of the Brain (ESGIB); ESCMID guideline: diagnosis and treatment of acute bacterial meningitis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2016 May;22 Suppl 3:S37-62 doi:10.1016/j.cmi.2016.01.007
[10] American Academy of Pediatrics. Committee on Infectious Diseases; Brady, Michael T.;Jackson, Mary Anne;Kimberlin, David W.;Long, Sarah S, Red Book: 2018-2021 Report of the Committee on Infectious Diseases, 31st Edition
[11] National Health Commission of the People's Republic of China. Notice on the issuance of three technical documents, including experts consensus on the clinical application of carbapenems. Medical Letter of the National Health Office [2018] No. 822.
[12] Bassetti M, Poulakou G, Ruppe E, et al. Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach. Intensive Care Med 2017; 43:1464–1475.
[13] Adrian J Brink; Epidemiology of carbapenem-resistant Gram-negative infections globally.Current opinion in infectious diseases 2019 12;32(6):609-616 doi:10.1097/QCO.0000000000000608
[14] Youhua Yuan, Junjie Wang, Zonghui Yao, Bing Ma, Yi Li, Wenjuan Yan, Shanmei Wang, Qiong Ma, Jiangfeng Zhang, Junhong Xu, Li Li, Yuming Wang, Enguo Fan; Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections and Outcomes.Infection and drug resistance 2020;13:207-215 doi:10.2147/IDR.S223243
[15] Elda Righi, Anna Maria Peri, Patrick N A Harris, Alexander M Wailan, Mariana Liborio, Steven W Lane, David L Paterson; Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.The Journal of antimicrobial chemotherapy 2017 03 01;72(3):668-677 doi:10.1093/jac/dkw459
[16] Isao Miyairi, Kensuke Shoji, Noriko Kinoshita, Junpei Saitoh, Yoshie Sugahara, Yasushi Watanabe, Makoto Komura, Masashi Kasai, Yuho Horikoshi, Masayoshi Shinjoh, Takashi Igarashi, Pediatric Infection Control Network (PICoNet) for the Japanese Association of Children’s Hospitals and Related Institutions (JACHRI); Prospective monitoring of carbapenem use and pseudomonal resistance across pediatric institutions.Infection control and hospital epidemiology 2020 Sep;41(9):1042-1047 doi:10.1017/ice.2020.234
[17] Tsubasa Akazawa, Yoshiki Kusama, Haruhisa Fukuda, Kayoko Hayakawa, Satoshi Kutsuna, Yuki Moriyama, Hirotake Ohashi, Saeko Tamura, Kei Yamamoto, Ryohei Hara, Ayako Shigeno, Masayuki Ota, Masahiro Ishikane, Shunichiro Tokita, Hiroyuki Terakado, Norio Ohmagari; Eight-Year Experience of Antimicrobial Stewardship Program and the Trend of Carbapenem Use at a Tertiary Acute-Care Hospital in Japan-The Impact of Postprescription Review and Feedback.Open forum infectious diseases 2019 Oct;6(10):ofz389 doi:10.1093/ofid/ofz389
[18] Myrto Eleni Flokas, Spyridon A Karageorgos, Marios Detsis, Michail Alevizakos, Eleftherios Mylonakis; Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis.International journal of antimicrobial agents 2017 May;49(5):565-572 doi:10.1016/j.ijantimicag.2017.01.008
[19] Manjiree V Karandikar, Carly E Milliren, Robin Zaboulian, Poornima Peiris, Tanvi Sharma, Andrew E Place, Thomas J Sandora; Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus Incidence.Journal of the Pediatric Infectious Diseases Society 2020 Sep 17;9(4):428-436 doi:10.1093/jpids/piz064
[20] Elena Ramírez, Rosa Gómez-Gil, Alberto M Borobia, Francisco Moreno, Claudia Zegarra, Raúl Muñoz, Zaida Reutero, Carolina de Montreuil, Diana González, Sonsoles Hernández, Alicia Herrero, Avelino Gutiérrez, Jesús Frías; Improving linezolid use decreases the incidence of resistance among Gram-positive microorganisms.International journal of antimicrobial agents 2013 Feb;41(2):174-8 doi:10.1016/j.ijantimicag.2012.10.017